These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D. Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306 [Abstract] [Full Text] [Related]
4. Perindopril plus nifedipine versus perindopril plus hydrochlorothiazide in mild to severe hypertension: a double-blind multicentre study. The Multicentre Study Group on Treatment Association with Perindopril. Letellier P, Overlack A, Agnes E, Desche P. J Hum Hypertens; 1994 Feb; 8(2):145-9. PubMed ID: 8207741 [Abstract] [Full Text] [Related]
5. Efficacy and acceptability of perindopril in essential hypertension. Sukonthasarn A, Ratanaprakarn R, Koanantakul B, Ngam-Ukos P. J Med Assoc Thai; 1994 Jun; 77(6):281-7. PubMed ID: 7869013 [Abstract] [Full Text] [Related]
6. Captopril versus perindopril: a double blind study in essential hypertension. Lees KR, Reid JL, Scott MG, Hosie J, Herpin D, Santoni JP. J Hum Hypertens; 1989 Feb; 3(1):17-22. PubMed ID: 2657055 [Abstract] [Full Text] [Related]
7. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial. Lacourcière Y, Poirier L, Hebert D, Assouline L, Stolt P, Rehel B, Khder Y. Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480 [Abstract] [Full Text] [Related]
8. Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring. Leenen FH, Wilson TW, Bolli P, Larochelle P, Myers M, Handa SP, Boileau G, Tanner J. Can J Cardiol; 1997 Oct; 13(10):914-20. PubMed ID: 9374947 [Abstract] [Full Text] [Related]
10. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension. Luccioni R, Sever PS, Di Perri T, Redon J, Laurandin I, Brault Y, Chastang C, Guez D. J Hypertens; 1995 Dec; 13(12 Pt 2):1847-51. PubMed ID: 8903665 [Abstract] [Full Text] [Related]
11. Multicenter evaluation of the efficacy and safety of sustained-release diltiazem hydrochloride for the treatment of hypertension. Woehler TR, Eff J, Graney W, Heald D, Ziemniak J, Magner D. Clin Ther; 1992 Dec; 14(2):148-57. PubMed ID: 1611639 [Abstract] [Full Text] [Related]
12. Comparison of the efficacy and tolerability of an angiotensin converting enzyme inhibitor (lisinopril) versus a calcium channel antagonist (diltiazem SR) in the treatment of moderate to severe hypertension. Weir MR, Fagan T, Chrysant S, Flamenbaum W, Kaihlanen PM, Lueg M, Anzalone D. J Hum Hypertens; 1994 Jul; 8(7):531-7. PubMed ID: 7932518 [Abstract] [Full Text] [Related]
13. 24-hour ambulatory blood pressure monitoring and spirapril in mild to severe essential hypertension: a randomized dose comparison. Vreugdenhil G, van Montfrans GA, Jacobs MC, de Bruijn JH, Veerman DP, van Es PN, Mellein B, Guitard C, Thien T, de Leeuw PW. Blood Press Suppl; 1994 Jul; 2():23-30. PubMed ID: 8061842 [Abstract] [Full Text] [Related]
14. Efficacy and tolerance of sustained-release diltiazem 300 mg and a diuretic in the elderly. Djian J, Roy M, Forette B, Lekieffre J, Luccioni R. J Cardiovasc Pharmacol; 1990 Jul; 16 Suppl 1():S51-5. PubMed ID: 1706015 [Abstract] [Full Text] [Related]
15. A comparison of valsartan and perindopril in the treatment of essential hypertension in the malaysian population. Bavanandan S, Morad Z, Ismail O, Chandran A, Thayaparan T, Singaraveloo M. Med J Malaysia; 2005 Jun; 60(2):158-62. PubMed ID: 16114156 [Abstract] [Full Text] [Related]
16. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension. Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators. Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192 [Abstract] [Full Text] [Related]
17. [Antihypertensive action, clinical and biological acceptability of perindopril: main results in 23,460 patients with mild to moderate hypertension treated for 6 months in general practice]. Fressinaud P, Berrut G, Gallois H. Ann Cardiol Angeiol (Paris); 1993 Jan; 42(1):51-9. PubMed ID: 8480986 [Abstract] [Full Text] [Related]
18. [Evaluation of the tolerance and effectiveness of Diltiazem LP 300 mg in hypertensive patients with chronic renal insufficiency]. Bernadet-Monrozies P, Poilleux E, Suc JM. Ann Cardiol Angeiol (Paris); 1998 Oct; 47(8):589-94. PubMed ID: 9809145 [Abstract] [Full Text] [Related]
19. Transdermal clonidine as an adjunct to sustained-release diltiazem in the treatment of mild-to-moderate hypertension. Lueg MC, Herron J, Zellner S. Clin Ther; 1991 Oct; 13(4):471-81. PubMed ID: 1933999 [Abstract] [Full Text] [Related]
20. [Duration of action of trandolapril in mild to moderate hypertensive patients evaluated by ambulatory measurement of blood pressure]. Kownator S, Dutrey-Dupagne C, Vaur L, Chevrier J, Diesel J, D'Hotel R, Schaaf R, Courvoisier A, Breton C. Therapie; 1994 Oct; 49(2):89-93. PubMed ID: 7817355 [Abstract] [Full Text] [Related] Page: [Next] [New Search]